Share Email Print

Proceedings Paper

Occlusion spectroscopy as a new paradigm for noninvasive blood measurements
Author(s): Ilya Fine; Boris Fikhte; Leonid D. Shvartsman
Format Member Price Non-Member Price
PDF $17.00 $21.00

Paper Abstract

We prove experimentally that RBC aggregation is among the major factors affecting time evolution of light transmission in both the normal situation of pulsatile blood flow and the situation of over-systolic vessel occlusion. Optical transmissions of tissue in vivo have been measured in red/near-infrared region. Sudden blood flow cessation causes the light transmission rising. For certain wavelengths range this growth becomes non-monotonic. The correspondence between in vivo measurements and the theoretical simulations is reached if we attribute the transmission growth to the change of average size of scatterers. The most important blood parameters such as hemoglobin, glucose, oxygen saturation, etc., influence the transmission growth following over-systolic occlusion and, therefore, may be extracted from the detailed analysis of the time evolution of optical transmission. It forms a basis for new kind of non-invasive measurements, i.e., occlusion spectroscopy. The results of in vivo clinical trials are presented for glucose and hemoglobin.

Paper Details

Date Published: 13 June 2001
PDF: 9 pages
Proc. SPIE 4263, Optical Diagnostics and Sensing of Biological Fluids and Glucose and Cholesterol Monitoring, (13 June 2001); doi: 10.1117/12.429330
Show Author Affiliations
Ilya Fine, OrSense Ltd. (Israel)
Boris Fikhte, OrSense Ltd. (Israel)
Leonid D. Shvartsman, Hebrew Univ. of Jerusalem and Generic Algorithms & Programs Ltd. (Israel)

Published in SPIE Proceedings Vol. 4263:
Optical Diagnostics and Sensing of Biological Fluids and Glucose and Cholesterol Monitoring
Alexander V. Priezzhev; Gerard L. Cote, Editor(s)

© SPIE. Terms of Use
Back to Top
Sign in to read the full article
Create a free SPIE account to get access to
premium articles and original research
Forgot your username?